期刊文献+

儿童携带卡他莫拉菌的耐药性及bro基因分型研究 被引量:2

Antibiotics Resistance and bro Genotyping in Moraxella Catarrhalis Isolates Carried by Children
在线阅读 下载PDF
导出
摘要 目的对儿童携带214株卡他莫拉菌分离株产酶率和9种抗生素敏感性测定,研究产酶株β-内酰胺酶耐药基因特征。方法采用英国抗生素化疗学会(BSCA)琼脂稀释法进行抗生素最小抑菌浓度测定;用Nitrocefin纸片琼脂扩散法检测β- 内酰胺酶;PCR扩增结合限制性内切酶分析方法对分离株进行bro基因分型。结果214株卡他莫拉菌中β-内酰胺酶产酶率为94.4%。产酶株对β-内酰胺类抗生素:氨苄西林、头孢呋辛、头孢克洛的MlC90分别为32 mg/L、2 mg/L和8 nag/L,明显高于非产酶株的0.5 mg/L,10 mg/L和0.5 mg/L;产酶株对氨苄西林、头孢呋辛、头孢克洛耐药率分别为95%、46.5%和76 2%,明显高于非产酶株组(0%)(x2=100.889,8.159,28.961 P均<0 001);产酶株与非产酶株组对头孢噻肟、非β-内酰胺类抗生素红霉素、环丙沙星、氯霉素和四环素敏感性无显著差异,其总体敏感性分别为100%、95.8%、100%、100%、34.1%,所有分离株对复方磺胺甲(口恶)唑产生耐药(100%),MIC50和MIC90高达32 mg/L和128 mg/L。202例产酶株经bro基因分型,69.8%(141/ 202)为bro—Ⅰ型,30.2%(61/202)为bro-Ⅱ型。bro-Ⅰ型携带菌株对β-内酰胺类抗生素的MIC50和MIC90高于bro-Ⅱ型的耐药株。结论北京地区携带的卡他莫拉菌β-内酰胺酶产酶率较高。 Objective To determine the beta-lactamase producing rate and susceptibility of nine antibiotics of 214 Moraxella Catarrhalis isolates carried by children and to investigate the characteristics of beta-lactamase resistant gene. Methods British Society for Antimicrobial Chemotherapy (BSAC) disk diffusion test and agar dilution test were taken to determine minimal inhibition concentration (MIC) and antibiotic resistance of Mc strains Nitrocefin disk test was used to detect beta-lactamase producing. PCR combining restriction endonuclease analysis was employed to do the bro genotyping. Results Among 214 strains, 94. 4% of them produced the beta-lactamase. The beta-lactamase producing isolates had the MIC90 32 mg/L for ampicillin, 2 mg/L for cefuroxime, and 8 mg/L for cefaclor, which were higher than the non beta-lactamase producing isolates 0. 5 mg/L, 1.0 mg/L and 0 5 mg/L respectively The resistant rates of beta-lactamase producing isolates were 95% for ampicillin, 46. 5% for cefuroxime, and 76 2% for cefaclor, which were also higher than non beta-lactamase producing isolates (0). There was no significant difference between beta-lactamase producing isolates and non beta-lactamase producing isolates in the susceptibility for cefotaxime, erythromycine, ciprofloxacin, tetracycline and chloramphenicol, with total susceptibility rates of 100% , 95 8% , 100% , 34.1 % and 100% , respectively. All of the isolates in this study were resistant to cotrimoxazole. 69.8% (141/202) of beta-lactamase producing isolates had bro-Ⅰ and 30. 2% (61/202) bro Ⅱ The isolates carrying gene of bro-Ⅰ had higher MIC50 and MIC90 than bro- Ⅱ strains. Conclusions There is high prevalence of beta-lactamase producing Moraxella Catarrhalis in Beijing children. Those isolates have high resistant rates to ampicillin. The dominant genotype for beta-lactamase producing isolates is bro-Ⅰ. The isolates carrying bro-Ⅰ gene are strongly resistant to beta-lactamase antibiotics than that carrying bro- Ⅱ gene.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2005年第5期423-426,共4页 Journal of Applied Clinical Pediatrics
基金 国家自然科学基金项目资助(30271377) 国家科技攻关计划项目资助(2003BA712A11-20)
关键词 卡他莫拉菌 抗生素耐药 bro基因 Moraxella Catarrhalis antibiotic resistance bro gene
  • 相关文献

参考文献10

  • 1王辉,朱家馨,刘勇,陈文昭,谢秀丽,徐英春,陈民钧.1999-2000年中国4所医院肺炎链球菌、流感嗜血杆菌及卡他莫拉菌的耐药现状[J].中国抗感染化疗杂志,2001,1(3):142-146. 被引量:69
  • 2Verduin CM, Hol C, Andre F, et al. Moraxella Catarrhalis: from emerging to established pathogen[J]. Clin Microbiol Rev, 2002,15(1):125 - 144.
  • 3Nakane K. A study of β - lactamase production and antimicrobial sensitivities in Moraxelle Catarrhalis strains isolated from children with upper or lower respiratory infections[J]. Jpn J Med Tech, 2002,51(10): 1391 - 1396.
  • 4Mignon du P. Rapid discrimination between BRO β- lactamase from clinical isolates of Moraxella Catarrhalis using restriction endonulease analysis[J]. Diagn Microbiol Infect Dis ,2001,39,65 - 67.
  • 5Jennifer M. Andrews for the BSAC Working Party on Susceptibility Testing. BSAC standardized disc susceptibility testing method[J]. J antimicro Chemoth, 2001,48 (suppl): S43 - S47.
  • 6Schmitz FJ, Beeck A, Perdikouli M,et al. Production of BROβ-lactamase and resistance to complement in european moraxelle catarrhalis isolates[J]. J Clin Microbio, 2002,40(4): 1546 - 1548.
  • 7Zhane GG, Palatnick L, Nichol KA, et al. Antimicrobial resistance in haemophilus influenzae and moraxelle catarrhalis respiratory organism susceptibility study, 1997 to 2002[J]. Antimicrob Agents Chemother, 2003,47(6): 1875 - 1881.
  • 8Bandak SI, Turnak MR, Allen BS, et al. Antibiotic susceptibilities among recent clinical isolates of haemophilus influenzae and moraxelle catarrhalis from fifteen countries[J]. Eur J Clin Microbiol Infect Dis, 2001,20: 55 - 60.
  • 9Karlowsky JA, Thornsberry C, Critchley Ian A, et al. Susceptibilities to levofloxacin in streptococcus pneumoniae, haemophilus influenzae and moraxelle catarrhalis clinical isolates from children: Results from 2000 - 2001 and 2001 - 2002. TRUST Studies in United States[J]. Antimicrob Agents Chemother, 2003, 47 (6):1790 -1797.
  • 10McGregor K, Chang BJ, Mee BJ,et al. Moraxelle Catarrhalis:clinical significance, antimicrobial susceptibility and BRO beta- lactamase[J]. J Clin Microbiol Infect Dis, 1998,17:219- 234.

二级参考文献12

  • 1杨永弘,王槿芳,俞桑洁,等. 北京地区儿童鼻咽部肺炎链球菌的携带率和耐药性及血清分型与携带危险因素[A]. 细菌耐药与抗感染研究进展. 全国细菌耐药与抗感染化疗药物合理应用学术会议选集[C]. 昆明,2000
  • 2Bartlett JG. Empirical therapy of community-acquired pneumoniae: macrolides are not ideal choices[J]. Semin Respir Infect, 1997,12(4): 329-333
  • 3Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibi otics in otitis media[J]. Pediatr Infect Dis J, 1996, 15: 255-259
  • 4Dagan R, Abramson O, Leibovitz E, et al. Bacteriologic response to oral cepha losporins: are established susceptibility breakpoints appropriate in the case of acute otitis media?[J]. J Infect Dis. 1997, 176(5): 1253-1259
  • 5Thornsberry C, Ogilvie P, Kahn J, et al. Surveillance of antimicro bial resist ance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrha lis in the United States in 1996-1997 respiratory season[A]. The Laboratory In ves tigator Group. Diagnostic Microbiology and Infectious Disease[M]. 1997, 29(4): 249-257
  • 6Pafller MA, Jones RN, Doern GV, et al. Bacterial pathogens isolate d from pati ents with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program[J]. Antimicrob. Agents and Chemother, 1998, 42(7): 1762-1770
  • 7National Committee for Clinical Laboratory Standards. Performance standards f or antimicrobial susceptibility testing: tenth informational supplement (aerobic dilution) M100-S10, 2000
  • 8Jacobs MR, Bajaksouzian S, Zilles A, et al. Susceptibility of Stre ptococcus p neumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on ph armacodynamic parameters: 1997 U.S. surveillance study[J]. Antimicrob Agents C hemother, 1999, 43(8): 1901-1908
  • 9Sahm DF, Jones ME, Hickey ML, et al. Resistance surveillance of St reptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia a nd Europe, 1997-1998[J]. J. Antimicrob Chemother, 2000, 45(4): 457-466
  • 10Wang H, Robin H, Chen M, et al. Antibiotic susceptibility pattern s of Strept ococcus pneumoniae in China and a comparison of minimum inhibitory concentration by agar dilution and E test methods[J]. Antimicrob Agents Chemother, 1998, 4 2(10): 2633-2636

共引文献68

同被引文献26

  • 1李冬,褚云卓,陈佰义.1999-2003年我院革兰阴性杆菌耐药性监测报告[J].中国医科大学学报,2005,34(3):268-269. 被引量:1
  • 2陶玉滨,杜民,司丹雁,关国坤.C反应蛋白在小儿急性呼吸道感染中的意义[J].中国误诊学杂志,2005,5(12):2226-2226. 被引量:3
  • 3王传清,王艺,王晓红,王爱敏,何磊燕,宋建明,薛建昌,沈叙庄,杨永弘.2000至2006年复旦大学附属儿科医院呼吸道感染患儿4种常见细菌分离率及耐药趋势[J].中国循证儿科杂志,2007,2(3):197-204. 被引量:15
  • 4PETROSILLO N, PANTOSTI A, BORDI E, et al. Prevalence determinants andmolecular epidemilogy of streptococcus pneumoniae isolates colonizing the nasopharynx of healthy children in Rome [ J ]. Eur J Clin Microbiol Infect Dis,2002,21 (3) :181-188.
  • 5LEE N Y, SONG J H, KIM S, et al. Carriage of antibiotic resistant pneumococci among Asian childrenia miltinationgal surveillance by the Asian Network for Survellance of Resistant Pathogens [ J ]. Clin Irffect Dis,2001,32(10) :1463-1469.
  • 6Bootsma HJ, van Dijk H, Vauterin P, et al. Genesis of BRO beta-lactamase-producing Moraxella catarrhalis: evidence for transformation mediated horizontal transfer [J]. Mol Micro- biol, 2000, 36(1): 93-104.
  • 7du Plessis M. Rapid discrimination between BRO beta-lacta- mases from clinical isolates of Moraxella catarrhalis using restriction endonuclease analysis [J]. Diagn Microbiol Infect Dis, 2001, 39(1): 65-67.
  • 8Bell JM, Tumidge JD, Jones RN. Development of a disk dif- fusion method for testing Moraxella catarrhalis susceptibility using clinical and laboratory standards institute methods: a SENTRY antimicrobial surveillance program report [J]. J Clin Microbiol, 2009, 47(7): 2187-2193.
  • 9Volkov IK, Katosova LK, Shcherbakova NIU, et al. Mo- raxella catarrhalis in chronic and relapsing respiratory tract infections in children [J]. Antibiot Khimioter, 2004, 49(8-9): 43-47[Russian].
  • 10Khan MA, Northwood JB, Levy F, et al. bro {beta}-lactamase and antibiotic resistances in a global cross-sectional study of Moraxella catarrhalis from children and adults [J]. J Antimi-erob Chemother, 2010, 65(1): 91-97.

引证文献2

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部